Juvenile and adult vulvar pemphigoid, an under recognized entity: Case series of fourteen patients.

Autor: Rashid H; Department of Dermatology, Center of Blistering Diseases, European Reference Network-Skin Member, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Oldhoff JM; Department of Dermatology, Center of Blistering Diseases, European Reference Network-Skin Member, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Esajas M; Department of Gynecology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Diercks GFH; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Pas HH; Department of Dermatology, Center of Blistering Diseases, European Reference Network-Skin Member, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Bolling MC; Department of Dermatology, Center of Blistering Diseases, European Reference Network-Skin Member, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Horváth B; Department of Dermatology, Center of Blistering Diseases, European Reference Network-Skin Member, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Jazyk: angličtina
Zdroj: JAAD case reports [JAAD Case Rep] 2021 May 24; Vol. 13, pp. 75-80. Date of Electronic Publication: 2021 May 24 (Print Publication: 2021).
DOI: 10.1016/j.jdcr.2021.05.017
Abstrakt: Competing Interests: Dr Horváth reports fees from 10.13039/100015756Janssen-Cilag (Advisory Boards, Educational grants, Consultations, Investigator Initiative Studies), 10.13039/100006483AbbVie (Advisory Boards, Educational grants, Consultations, Investigator Initiative Studies), Novartis Pharma (Advisory Boards, Consultations, Investigator Initiative Studies), UCB Pharma (Advisory Boards, Consultations), Leo Pharma (Consultations), Solenne B.V. (Investigator Initiative Studies), Celgene (Consultations, Investigator Initiative Studies), Akari therapeutics (Consultations, Investigator Initiative Studies), Philips (Consultation), Roche (Consultation), Regeneron (Consultation) and Sanofi (Consultation), which fees were paid to the institution. The remaining authors declare no conflict of interest.
Databáze: MEDLINE
Externí odkaz: